András Balogh

András Balogh

Auto-generated profile, based on publicly available information

András Balogh

Experimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, Germany

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2017 in Nature
Verified
Journal Article
Closed access
PDF file
NWNicola Wilck
Nicola Wilck
MMMariana G. Matus
Mariana G. Matus
SKSean M. Kearney
Sean M. Kearney
SOScott Olesen
Scott Olesen
KFKristoffer Forslund
Kristoffer Forslund
DMDominik Muller
Dominik Muller

1 October 2015 in Immunity
Verified
Journal Article
Closed access
AHAiden Haghikia
Aiden Haghikia
SJStefanie Jörg
Stefanie Jörg
ADAlexander Duscha
Alexander Duscha
JBJohannes Berg
Johannes Berg
AMArndt Manzel
Arndt Manzel
RLRalf Linker
Ralf Linker

28 January 2016 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
LMLajos Marko
Lajos Marko
EVEmilia Vigolo
Emilia Vigolo
CHChristian Hinze
Christian Hinze
JPJoon-Keun Park
Joon-Keun Park
GRGiulietta Roël
Giulietta Roël
DMDominik Muller
Dominik Muller
NF-κB is a key regulator of innate and adaptive immunity and is implicated in the pathogenesis of AKI. The cell type–specific functions of NF-κB in the kidney are unknown; however, the pathway serves distinct functions in immune and tissue parenchymal cells. We analyzed tubular epithelial-specific NF-κB signaling in a mouse model of ischemia-reperfusion injury (IRI)–induced AKI. NF-κB reporter activity and nuclear localization of phosphorylated NF-κB subunit p65 analyses in mice revealed that IRI induced widespread NF-κB activation in renal tubular epithelia and in interstitial cells that peaked 2–3 days after injury. To genetically antagonize tubular epithelial NF-κB activity, we generated mice expressing the human NF-κB super-repressor IκBαΔN in renal proximal, distal, and collecting duct epithelial cells. Compared with control mice, these mice exhibited improved renal function, reduced tubular apoptosis, and attenuated neutrophil and macrophage infiltration after IRI-induced AKI. Furthermore, tubular NF-κB–dependent gene expression profiles revealed temporally distinct functional gene clusters for apoptosis, chemotaxis, and morphogenesis. Primary proximal tubular cells isolated from IκBαΔN-expressing mice and exposed to hypoxia-mimetic agent cobalt chloride exhibited less apoptosis and expressed lower levels of chemokines than cells from control mice did. Our results indicate that postischemic NF-κB activation in renal tubular epithelia aggravates tubular injury and exacerbates a maladaptive inflammatory response.

1 April 2016 in Immunity
Verified
Journal Article
Closed access
AHAiden Haghikia
Aiden Haghikia
SJStefanie Jörg
Stefanie Jörg
ADAlexander Duscha
Alexander Duscha
JBJohannes Berg
Johannes Berg
AMArndt Manzel
Arndt Manzel
RLRalf A. Linker
Ralf A. Linker

1 August 2016 in Neuroscience
Verified
Journal Article
Closed access
VKViktória Kormos
Viktória Kormos
LGLászló Gáspár
László Gáspár
LKLászló Á. Kovács
László Á. Kovács
JFJózsef Farkas
József Farkas
TGTamás Gaszner
Tamás Gaszner
Balazs GasznerBalazs Gaszner
Balazs Gaszner

22 February 2018 in JCI Insight
Verified
Journal Article
Open access
PDF file
NWNicola Wilck
Nicola Wilck
LMLajos Marko
Lajos Marko
ABAndrás Balogh
András Balogh
KKKristin Kräker
Kristin Kräker
FHFlorian Herse
Florian Herse
NHNadine Haase
Nadine Haase
Heart failure with preserved ejection fraction (HFpEF) can arise from cardiac and vascular remodeling processes following long-lasting hypertension. Efficacy of common HF therapeutics is unsatisfactory in HFpEF. Evidence suggests that stimulators of the nitric oxide–sensitive soluble guanylyl cyclase (NOsGC) could be of use here. We aimed to characterize the complex cardiovascular effects of NOsGC stimulation using NO-independent stimulator BAY 41-8543 in a double-transgenic rat (dTGR) model of HFpEF. We show a drastically improved survival rate of treated dTGR. We observed less cardiac fibrosis, macrophage infiltration, and gap junction remodeling in treated dTGR. Microarray analysis revealed that treatment of dTGR corrected the dysregulateion of cardiac genes associated with fibrosis, inflammation, apoptosis, oxidative stress, and ion channel function toward an expression profile similar to healthy controls. Treatment reduced systemic blood pressure levels and improved endothelium-dependent vasorelaxation of resistance vessels. Further comprehensive in vivo phenotyping showed an improved diastolic cardiac function, improved hemodynamics, and less susceptibility to ventricular arrhythmias. Short-term BAY 41-8543 application in isolated untreated transgenic hearts with structural remodeling significantly reduced the occurrence of ventricular arrhythmias, suggesting a direct nongenomic role of NOsGC stimulation on excitation. Thus, NOsGC stimulation was highly effective in improving several HFpEF facets in this animal model, underscoring its potential value for patients.